Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advance care planning in metastatic breast cancer.
Matsuoka J, Kunitomi T, Nishizaki M, Iwamoto T, Katayama H. Matsuoka J, et al. Chin Clin Oncol. 2018 Jun;7(3):33. doi: 10.21037/cco.2018.06.03. Chin Clin Oncol. 2018. PMID: 30056735 Free article. Review.
Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial.
Sugiu K, Iwamoto T, Kelly CM, Watanabe N, Motoki T, Ito M, Ohtani S, Higaki K, Imada T, Yuasa T, Omori M, Sonobe H, Fujiwara T, Matsuoka J. Sugiu K, et al. Among authors: matsuoka j. Acta Med Okayama. 2015;69(5):291-9. doi: 10.18926/AMO/53675. Acta Med Okayama. 2015. PMID: 26490026 Free article. Clinical Trial.
A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer.
Yoshitomi S, Taira N, Doihara H, Mizoo T, Nogami T, Iwamoto T, Motoki T, Shien T, Ogasawara Y, Matsuoka J, Tsuji H, Mitsuhashi T. Yoshitomi S, et al. Among authors: matsuoka j. Cancer Chemother Pharmacol. 2016 Aug;78(2):289-94. doi: 10.1007/s00280-016-3091-x. Epub 2016 Jun 17. Cancer Chemother Pharmacol. 2016. PMID: 27316438 Clinical Trial.
Current Multidisciplinary Approach to Fertility Preservation for Breast Cancer Patients.
Takahashi Y, Shien T, Sakamoto A, Tsuyumu Y, Yoshioka R, Uno M, Hatono M, Kochi M, Kawada K, Tsukioki T, Iwamoto T, Ikeda H, Taira N, Matsuoka J, Nakatsuka M, Doihara H. Takahashi Y, et al. Among authors: matsuoka j. Acta Med Okayama. 2018 Apr;72(2):137-142. doi: 10.18926/AMO/55854. Acta Med Okayama. 2018. PMID: 29674762 Free article.
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Takahashi Y, Iwamoto T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kawada K, Kochi M, Ikeda H, Shien T, Taira N, Matsuoka J, Doihara H, Toyooka S. Takahashi Y, et al. Among authors: matsuoka j. Clin Breast Cancer. 2020 Apr;20(2):117-124.e4. doi: 10.1016/j.clbc.2019.07.001. Epub 2019 Sep 9. Clin Breast Cancer. 2020. PMID: 31570267 Free article.
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M, Iwamoto T, Matsuoka J, Nogami T, Motoki T, Shien T, Taira N, Niikura N, Hayashi N, Ohtani S, Higaki K, Fujiwara T, Doihara H, Symmans WF, Pusztai L. Itoh M, et al. Among authors: matsuoka j. Breast Cancer Res Treat. 2014 Jan;143(2):403-9. doi: 10.1007/s10549-013-2763-z. Epub 2013 Dec 15. Breast Cancer Res Treat. 2014. PMID: 24337596 Free article.
N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.
Hara A, Taira N, Mizoo T, Nishiyama K, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Miyoshi S. Hara A, et al. Among authors: matsuoka j. Breast Cancer. 2017 Mar;24(2):254-262. doi: 10.1007/s12282-016-0696-1. Epub 2016 Apr 11. Breast Cancer. 2017. PMID: 27068825 Free article.
250 results